Christina Bresani

Ms. Bresani, managing director and head of Corporate Advisory, has over 23 years of investment banking experience. Before joining William Blair, she spent her entire career with UBS in New York focused exclusively on M&A. Over her career, she has executed more than 70 transactions with an aggregate transaction value in excess of $180 billion. Over the past two decades, Ms. Bresani has completed industry-shaping transactions involving private and publicly traded companies across the financial services, healthcare, real estate, services and industrials sectors, including Chicago Board Options Exchange’s $3.8 billion acquisition of Bats Global Markets, TIAA’s $2.5 billion acquisition of EverBank Financial, Eli Lilly’s $6.5 billion acquisition of ImClone, and the $30.3 billion merger of Caremark Rx and CVS. Ms. Bresani earned her bachelor’s degree in 1998 from Wellesley College in Massachusetts.